Consonance HFW
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Consonance HFW and buy or sell other stocks, ETFs, and their options commission-free!About CHFW
Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K.
CEOCraig C. Parker, MBA
CEOCraig C. Parker, MBA
Employees41
Employees41
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees41
Employees41
CHFW Key Statistics
Market cap83.91M
Market cap83.91M
Price-Earnings ratio-1.13
Price-Earnings ratio-1.13
Dividend yield—
Dividend yield—
Average volume144.54K
Average volume144.54K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$24.94
52 Week high$24.94
52 Week low$5.90
52 Week low$5.90
Stock Snapshot
Consonance HFW(CHFW) stock is priced at $9.79, giving the company a market capitalization of 83.91M. It carries a P/E multiple of -1.13.
During the trading day, Consonance HFW(CHFW) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 144.54K.
The stock's 52-week range extends from a low of $5.90 to a high of $24.94.
The stock's 52-week range extends from a low of $5.90 to a high of $24.94.
People also own
Based on the portfolios of people who own CHFW. This list is generated using Robinhood data, and it’s not a recommendation.